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In the mammalian central nervous system transcripts of certain synaptic components are localized
near the synapse, allowing for rapid regulation of protein levels. Here we test whether an mRNA
localization mechanism also exists in the postsynaptic specialization induced by agrin in C2C12
myotubes. RT-PCR showed that Chrna1 was co-puriﬁed with nicotinic acetylcholine receptor (AChR)
isolated by afﬁnity column or by ultracentrifugation. In addition, Stau1 was found to interact with
Chrna1 mRNA, and knocking down of Stau1 by RNAi resulted in defective AChR clustering. These
results suggest that mRNA localization also participates in the formation of mammalian neuromus-
cular junction (NMJ).
Structured summary of protein interactions:
AChR alpha 1 physically interacts with Stau1 by pull down (View interaction)
 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Localization of mRNA near the site of protein function has been
reported in the central nervous system (CNS) synapses where the
transcripts of certain synaptic components are targeted to den-
drites [1–3]. Such design may allow the translation of these synap-
tic components to be rapidly modulated by regulatory signals
acting on the synapse, and prevent mis-targeting of the newly syn-
thesized synaptic proteins [4–6]. The mRNAs of neurotransmitter
receptors, including glycine receptor a subunit, NMDA receptor
NR1 subunit, and AMPA receptor subunits GluR 1 and 2, are den-
dritically localized in the CNS [7–10]. The transcripts of at least
two neurotransmitter receptors are found anchored with theirchemical Societies. Published by E
euromuscular junction; BTX,
titute of Natural Products,
Road, Kaohsiung City 807,
).own receptors. The mRNAs of GABAB receptor subunits, R1 and
R2, are associated with the receptor through the RNA binding pro-
tein Marlin-1 [9]. Marlin-1 down-regulation by RNA interference
results in reduced levels of GABAB R2 mRNA, suggesting Marlin-1
also regulates the abundance of speciﬁc GABAB receptors via the
control of RNAmetabolism [9]. Electronmicroscopic in situ hybrid-
ization shows that GlyR a subunit mRNA is associated with the
postsynaptic differentiation of glycinergic synapses [10]. Synaptic-
ally localized GlyR a subunit mRNAs may allow for local synthesis
of new a subunits that could then rapidly assemble to form the
homo- or heteromeric receptors [10].
The neuromuscular junction (NMJ) has been intensely studied
as a model for the formation of synaptic specialization. In the post-
synaptic membrane of NMJ, the nicotinic acetylcholine receptors
(AChRs) are clustered at high density along with other major
postsynaptic components. The organization of this postsynaptic
specialization is triggered by agrin released from the axonal termi-
nals of the motor neuron. mRNAs coding for AChR subunits, and
synaptic scaffold proteins such as a-dystrobrevin and utrophin,
are concentrated in NMJs [11–15]. Emerging evidence suggestslsevier B.V. All rights reserved.
3112 Y.-F. Chang et al. / FEBS Letters 586 (2012) 3111–3116that post-transcriptional regulation may also contribute to the
restricted distribution of synaptic transcripts and the normal
functioning of NMJ [16–18]. Moreover, mRNA binding proteins
including Stau-1 are also co-localized with AChR at postsynaptic
NMJs [19,20], but the functional signiﬁcance has not yet been
determined.Fig. 1. Association of Chrna1 mRNA with agrin-induced postsynaptic specialization
in C2C12 myotubes. (A) Presence of Chrna1 mRNA in postsynaptic specializations.
Postsynaptic specializations induced by agrin in C2C12 myotubes were isolated by
afﬁnity puriﬁcation using magnetic beads conjugated with a-bungarotoxin. The
associated RNA was puriﬁed and the presence of transcripts encoding AChR a1 was
detected by RT-PCR. Transcripts for b-actin and Gapdh served as the control of
residual RNAs that showed no speciﬁc binding. BTX+, pull-down using a-bunga-
rotoxin beads. BTX; pull-down using empty beads. (B) The differences in Chrna1
and Gapdh Ct values between pulled-down RNA and 12 pg agrin-treated C2C12
total RNA as templates were determined. Columns, averaged DCt from triplicate
qRT-PCR experiments; bars, SD. ⁄⁄p < 0.01.2. Materials and methods
2.1. Induction of postsynaptic specialization in C2C12 myotubes
C2C12 myoblast cultures were maintained in growth medium
(DMEM containing 20% fetal calf serum, 2 mM glutamine, and pen-
icillin/streptomycin). Differentiation was induced by switching
myoblast cultures with 70% conﬂuence to the fusion medium
(DMEM containing 5% horse serum, 2 mM glutamine), and the
medium was refreshed daily. AChR clusters were induced by add-
ing 0.1 lg/ml recombinant z8 neural c-agrin (R&D Systems) to fully
differentiated myotube culture overnight. Twenty microgram per
milliliters cycloheximide (Sigma) was added with agrin to inhibit
protein translation when necessary. To visualize AChR clustering,
the cells were ﬁxed in 2% paraformaldehyde for 5 min, stained with
rhodamine-labeled a-bungarotoxin (Molecular Probes), rinsed
with PBS, and viewed under a ﬂuorescent microscope. To measure
the length distribution of AChR clusters, digital photographs were
taken from three random microscopic ﬁelds and the lengths of
AChR clusters were measured using ImageJ (http://rsb-
web.nih.gov/ij/index.html).
2.2. Pull-down assays
To pull down surface AChR complexes, 5 lg biotinylated a-bun-
garotoxin (Molecular Probe) was incubated with intact C2C12
myotubes in each 10-cm culture dish for 90 min at 4 C prior to
homogenization. C2C12 myotubes were washed twice with ice-
cold TBS and resuspended in 1 ml TBS with 0.1% Triton. The cells
were then homogenized by pipetting up and down for 20 times
using a 1 ml blue tip. The homogenate was centrifuged at
12000 rpm at 4 C for 10 min to remove undissolved debris. To pull
down AChR-containing postsynaptic complexes, 1 ml cleared myo-
tube lysate was mixed with 50 ll slurry of avidin-conjugated mag-
netic beads (Invitrogen). Immunoprecipitation of protein complex
was performed by using M270 magnetic beads (Invitrogen) conju-
gated with anti-Stau1 antibody (AB5781, Chemicon) or anti-AChR
a1 antibody (LS-C34792, LSBio). In all cases, after 2 h incubation
with gentle agitation at 4 C, the magnetic microbeads were pulled
down by using a magnetic stand, and washed four times with 1 ml
TBS containing 0.1% Triton. RNase inhibitor (Sigma, R7397) and
protease inhibitors (Sigma, P8340) were added to the lysates at
all times.
2.3. RT-PCR analyses
RNA was extracted from the microbeads by using 100 ll Trizol
reagent and ﬁnally dissolved in 10 ll nuclease-free water. The
presence of synaptic transcripts was detected by 10 ll One-step
RT-PCR (Invitrogen) reaction using 1 ll puriﬁed RNA as template.
Single color quantitative RT-PCR was performed in a BioRad
iCycler. The primers used were as follows: Chrna1, forward:
50TCATCATTCCCTGCCTGCTCTTCT30, reverse: 50TCTCTGCAATGTAC-
TTCACGCCCT30; Actb, forward: 50CACTATCGGCAATGAGCGGTTCC30,
reverse: 50TGCATCCTGTCAGCAATGCCTG30; Gapdh, forward:
50GCACAGTCAAGGCCGAGAAT30, reverse: 50GCCTTCTCCATGGTGG-
TGAA30. The real-time PCR results were analyzed by the compara-
tive Ct method [21]. Brieﬂy, agrin-induced fold enrichment ofChrna1 mRNA in pull down assays was calculated from 2DDCt,
where DDCt =D(CtChrna1  CtActn). Ct, threshold cycle.
2.4. Western blotting
The microbeads from each pull down assay were mixed with
20 ll 1 SDS sample buffer, heated at 75 C for 10 min, and sub-
jected to SDS–PAGE using precast NuPAGE Novex 4–12% Bis-Tris
gradient gels (Invitrogen). After electrophoresis at 200 V for
40 min, the proteins were transferred to a PVDF membrane, de-
tected by antibodies, and visualized by protein detector Lumiglo
(KPL). Antibodies used were: anti-AChR a1 monoclonal antibody
mAb 210 (Sigma), rabbit anti-CHRNB1 polyclonal antibody (Sig-
ma), anti-Rapsyn mAb clone 1234 (Sigma) and anti-Stau1 antibody
AB5781 (Chemicon). Representative results of at least triplicate
experiments are shown.
2.5. Equilibrium density gradient ultracentrifugation
Discontinuous density sucrose gradients were formed by layer-
ing ten 1 ml layers of TBST solution containing 15–40% sucrose in
2.5% increments, with progressively less dense sucrose solutions
upon one another. One milliliter cleared myotube lysate was lay-
ered on the very top of the sucrose layers, and centrifuged ﬁrst
at 20 K rpm (34,600g) for an hour and then at 90 K rpm
(700,000g) for 8 h at 4 C (P90AT rotor, CP100MX, Hitachi). Upon
the completion of centrifugation, samples were carefully removed
from the top to bottom in 1 ml fractions. Fifty microliters of each
fraction was spotted on a PVDF membrane using a dot-blotter,
and the presence of AChR a1 subunit was detected following the
Western blotting procedure described above. RNA from 10 ll solu-
tion of each fraction was extracted using 100 ll Trizol, and 1/10 of
the puriﬁed RNA was used as the template for RT-PCR analysis of
synaptic transcripts.
2.6. RNAi knock-down of Stau1
RNAi reagents, including ﬁve pLKO.1-shStau1 plasmids
(TRCN0000102305-9) and the control pLKO.1-shLuc plasmid, were
obtained from the National RNAi Core Facility (Institute of Molec-
ular Biology/Genomic Research Center, Academia Sinica, Taipei,
Fig. 2. The association of Chrna1 mRNA with postsynaptic specialization required agrin stimulation. (A) The presence of Chrna1 mRNA in the AChR-containing complexes
from the whole cell lysates of myotubes treated with or without agrin was detected by RT-PCR. The pull-down of AChR protein was detected by Western blotting. Agrin:
postsynaptic specialization was induced by overnight agrin incubation (left panel). AChR b1 subunit and the postsynaptic scaffold protein rapsyn were also detected by
Western blotting after BTX pull-down of agrin-treated myotube lysate (right panel). (B) Co-separation of Chrna1 mRNA and AChR by equilibrium density gradient
ultracentrifugation through a 15–40% discontinuous sucrose gradient. The majority of AChR was found in the fractions with 22.5–25% sucrose as detected by dot blot using
anti-AChR a1 antibody (upper panel). These two fractions were pooled together and the presence of Chrna1 and ActbmRNAs in these fractions was detected by RT-PCR (lower
panel). Chrna1 mRNA showed speciﬁc association with AChR a1 after agrin stimulation. The expression levels of AChR a1 mRNA (C) and protein (D) were not signiﬁcantly
affected by overnight treatment of agrin. Columns, averaged Ct value differences from triplicate qRT-PCR experiments; bars, SD. Ag, overnight agrin treatment.
Fig. 3. Similar time course in agrin-induced Chrna1mRNA localization and AChR clustering. (A) C2C12 myotubes were treated with agrin for 0–6 h. The association of Chrna1
mRNA with afﬁnity-puriﬁed AChR was analyzed by end-point (upper panel) and quantitative RT-PCR (lower panel). Columns, average fold enrichment of Chrna1 after BTX
pull-down following agrin treatment for the indicated times. Values are from triplicate qRT-PCR experiments calculated by theDDCt method; bars, SD. ⁄⁄p < 0.01 as compared
with 0 h. (B) In parallel cultures the AChR clusters were detected with rhodamine-labeled a-bungarotoxin and visualized by ﬂuorescent microscopy. Scale bar: 50 lm.
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transfecting 293T cells with ﬁve pLKO.1-shStau1 plasmids that to-
gether target ﬁve regions of Stau1 mRNA, and two packaging plas-
mids, pCMV-D8.91 and pMD.G. C2C12 myoblasts were infected on
the day of the induction of differentiation at a multiplicity of infec-
tion (MOI) of 100.
2.7. Statistical analysis
All of the results are shown as the mean ± SD from at least three
independent experiments. The data were analyzed by Student’s T-
test. A P-value < 0.05 was considered as statistically signiﬁcant. The
asterisks of this paper represent the result of ⁄p < 0.05 and
⁄⁄p < 0.01.3. Results
3.1. Detection of transcripts associated with agrin-induced
postsynaptic specialization
C2C12 myotube cultures were used as an in vitro model to
examine whether certain synaptic transcripts are associated with
postsynaptic specialization in muscles. The synaptogenic protein
agrin was used to induce postsynaptic differentiation including
clustering of AChR and recruiting of postsynaptic components to
the receptor clusters. The myotubes were then gently homoge-
nized to allow AChR and the associated postsynaptic complexes
to be pulled down by magnetic beads coated with a-bungarotoxin.
The RNAs within the precipitated complexes were puriﬁed and the
Fig. 4. Stau1 mediates the association of Chrna1 mRNA and the AChR complex. (A)
Agrin induced the association of Stau1 protein and Chrna1 mRNA. The presence of
Chrna1mRNA in protein complexes pulled down by microbeads conjugated with a-
bungarotoxin, anti-Stau1 antibody, or anti-AChR a1antibody was detected by RT-
PCR. Empty avidin beads were used as negative control. (B) Stau1 protein was
detected by Western blotting in the complexes pulled down by BTX beads or by
anti-AChR a1immunoprecipitation after agrin treatment. C2C12 myotubes were co-
treated with cycloheximide to prevent agrin from increasing Stau1 protein levels.
(C) Agrin-induced speciﬁc binding of Chrna1 mRNA to BTX microbeads was not
affected by inhibition of translation by cycloheximide. (D) Knockdown of Stau1
expression in C2C12 myotubes by RNAi. Three days after lentivirus-mediated RNAi
in C2C12 myotubes, the reduction in Stau1 protein levels was conﬁrmed by
Western blotting. (E) Stau1 down regulation reduced the association of Chrna1
mRNA with AChR. C2C12 myotubes expressing sh-Stau1 or sh-luciferase were
treated with agrin overnight and the presence of Chrna1 mRNA in postsynaptic
specializations pulled down by a-bungarotoxin beads was analyzed by end-point
(upper panel) and quantitative RT-PCR (lower panel). Columns, averaged fold
enrichment of Chrna1 after BTX pull-down following agrin treatment. Values are
from triplicate qRT-PCR experiments; bars, SD; CHX, cycloheximide. ⁄p < 0.05.
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(gene symbol: Chrna1) was detected by RT-PCR. Chrna1 mRNA dis-
played speciﬁc binding to the postsynaptic complex (compared to
binding to empty beads), whereas ubiquitously distributed tran-
scripts of b-actin and Gapdh showed no enhanced binding
(Fig. 1A).
Comparing the threshold cycles of Actb in a qRT-PCR titration
experiment by using a 10-fold dilution series of total RNA isolated
from agrin-treated C2C12 lysate and RNAs isolated from the pull-
down assay as templates, allowed us to determine that RNAs iso-
lated from the pull-down assay contained amounts of Actb mRNA
equal to that in 12 pg of total RNA from the C2C12 cell lysate.
Hence we compared the Chrna1 Ct value of 12 pg C2C12 myotube
total RNA with that of RNAs isolated from BTX beads. Chrna1
showed signiﬁcantly higher DCt value whereas Gapdh did not.
This result indicates that Chrna1 mRNA is enriched by BTX pull-
down, thereby supporting the speciﬁc association of Chrna1 mRNA
with the postsynaptic complex (Fig. 1B).
We then examined the effect of agrin stimulation on the pres-
ence of Chrna1 mRNA in the postsynaptic specialization. Analyses
of the BTX pull-down by RT-PCR andWestern blotting showed that
Chrna1 mRNA associated with AChR a1 only after the myotubes
had been treated with agrin (Fig. 2A, left panel). In addition to
AChR a1, AChR b1 and rapsyn were also detected by Western blot-
ting in the BTX pull-down of agrin-treated myotube lysate, indicat-
ing Chrna1 mRNA was associated with the postsynaptic complex
(Fig. 2A, right panel). Quantitative RT-PCR indicated that agrin
stimulation increased the levels of Chrna1 mRNA associated with
surface receptor complexes by 12.7 ± 3.3-fold (mean ± SD, n = 3).
In addition to afﬁnity puriﬁcation, a second method was used to
further conﬁrm the agrin-induced association of Chrna1 mRNA
with AChR-containing postsynaptic specialization. AChR-contain-
ing postsynaptic complexes have been shown to be present in
detergent (Triton X-100)-resistant membranes that can be isolated
by equilibrium density gradient ultracentrifugation [22]. Therefore
we resolved the homogenates of C2C12 myotubes by discontinu-
ous sucrose gradient ultracentrifugation. The distribution of AChR
was determined by dot blotting using anti-AChR a1 antibody to
be mainly in the 22.5–25% fractions regardless of agrin treatment
(Fig. 2B, upper panel). This result is consistent with the previous
report that AChR associates with detergent-resistant membrane
fractions independent of agrin signaling [22]. RT-PCR analysis of
pooled RNAs extracted from these fractions also indicated that
agrin induces the binding of Chrna1 mRNA to AChR complexes
(Fig. 2B, lower panel). Possible changes of Chrna1 mRNA and pro-
tein levels due to agrin stimulation were assessed by qRT-PCR
and Western blotting, respectively. In agreement with previous
studies [23,24], agrin did not alter the levels of Chrna1 mRNA
(Fig. 2C), or AChR a1 protein (Fig. 2D). Therefore, the induced asso-
ciation of Chrna1 mRNA with postsynaptic complexes is not likely
to be the result of increased expression of the mRNA or protein of
AChR a1 subunit.
3.2. Agrin induces Chrna1 mRNA localization and AChR clustering with
a similar time course
To determine when the localization of Chrna1mRNA takes place
during the formation of agrin-induced postsynaptic specialization,
we compared the time course of the association of Chrna1 mRNA
with the postsynaptic specialization to that of AChR clustering, in
myotubes treated with agrin for 0, 2, 4, and 6 h. The Chrna1 mRNA
was detected in the afﬁnity-puriﬁed AChR complex as early as 4 h
after agrin stimulation, and the association signiﬁcantly increased
at 6 h and remained stable overnight (Fig. 3A). In comparison, the
micro-clusters of AChR became visible at 4 h and further aggre-
gated to form full size clusters at 6 h after agrin stimulation(Fig. 3B). These data suggest that Chrna1 mRNA starts to associate
with postsynaptic components when the micro-clusters of AChR
appear and start to aggregate to form full size clusters.
3.3. Stau1 participates in Chrna1 mRNA localization and AChR
clustering
A previous report indicated that the RNA binding protein Stau1
is localized in the postsynaptic specialization in muscle cells and
co-clustered with AChR in agrin-treated C2C12 myotubes [19],
suggesting that Stau1 may participate in the agrin-induced post-
synaptic development by regulating the localization of Chrna1
mRNA. To examine whether Stau1 binds Chrna1 mRNA in agrin-
stimulated myotubes, magnetic beads conjugated with a-Stau1
antibody were used to pull down Stau1 protein along with the
associated RNA. RT-PCR analysis showed that Chrna1 mRNA was
indeed associated with Stau1 in an agrin-depended manner
(Fig. 4A). Since agrin has been shown to mildly enhance Stau1 pro-
tein expression [19], the association of Stau1 with the postsynaptic
complex and with Chrna1 mRNA was further investigated in
the presence of the translation inhibitor cycloheximide. Agrin
stimulation did not affect total Stau1 levels in the presence of
Fig. 5. Effect of Stau1 knockdown on agrin-induced AChR clustering in C2C12 myotubes. C2C12 myotubes expressing sh-Stau1 or sh-luciferase were treated with agrin
overnight and the AChR clusters were detected with rhodamine-labeled a-bungarotoxin and visualized by ﬂuorescent microscopy. (A) AChR clusters in myotubes expressing
sh-Stau1 were shorter and less organized compared to those in control myotubes expressing off-target shRNA against luciferase. Scale bar: 50 lm. The lengths of AChR
clusters were measured by ImageJ and the histogram showing the shift of length distributions is presented in (B).
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postsynaptic complex (Fig. 4B). In addition, the enrichment of
Chrna1 mRNA in the BTX pull-down assay was not affected by
cycloheximide (Fig. 4C), thus excluding the possibility that the
above results showing agrin-dependent interaction between
Chrna1 mRNA, Stau1, and AChR are actually caused by agrin-in-
duced changes of expression levels in these molecules.
To further conﬁrm the role of Stau1 in mediating the association
of Chrna1 mRNA with the postsynaptic complex, Stau1 expression
was repressed by lentivirus-mediated RNA interference and the
effectiveness of Stau1 down regulated in C2C12 myotubes was
examined by Western blotting (Fig. 4D). Reduction of Stau1 signif-
icantly decreased the association of Chrna1mRNA with AChR com-
plexes, as detected by RT-PCR (Fig. 4E).
To determine the functional signiﬁcance of Stau1 in the forma-
tion of postsynaptic specialization of NMJ, agrin-induced AChR
clustering in myotubes expressing shStau1 or off-target control
shLuc were detected by rhodamine-conjugated a-bungarotoxin
and ﬂuorescence microscopy. The AChR clusters appeared disar-
rayed and shorter in myotubes expressing shSatu1 compared to
those expressing shLuc (Fig. 5A). The frequency plot of AChR clus-
ter length showed that in myotubes with down-regulated Stau1,
most AChR clusters were shorter than 20 lm (98.3%; Fig. 5B, grey
columns). In contrast, a signiﬁcant portion of AChR clusters were
longer than 20 lm in control myotubes (21.6%, Fig. 5B, dark col-
umns). One way ANOVA analysis indicated the cluster length dis-
tribution was signiﬁcantly different between these two types of
myotubes (F = 246.8, P < 0.01).
4. Discussion
It has been suggested that post-transcriptional regulation con-
tributes to the restricted distribution of synaptic transcripts inNMJ [16]. In this study, we found that Chrna1 mRNA was detected
in the AChR-containing postsynaptic complexes, either isolated by
afﬁnity puriﬁcation using immobilized a-bungarotoxin or fraction-
ated by sucrose density gradient ultracentrifugation from the
homogenates of agrin-treated C2C12 myotubes. Agrin–induced
association of Chrna1 mRNA with AChR occurred as early as 4 h
after the stimulation and increased pronouncedly at 6 h and per-
sisted overnight, suggesting that the RNA localization is activated
by agrin as a part of the process of NMJ formation.
In muscle ﬁbers, synaptic transcripts are speciﬁcally transcribed
by the subsynaptic nuclei situated closely under the postsynaptic
membrane [25]. The RNA localization mechanism may anchor
the synaptic transcripts and prevent the diffusion of these tran-
scripts away from NMJ. Ultrastructure studies have shown that
the tiny space of sarcoplasm between the subsynaptic nuclei and
the junctional fold is crammed with Golgi apparatus, rough endo-
plasmic reticulum and ribosomes [26]. The close proximity to the
protein translation and modiﬁcation machineries would allow
the synaptic transcripts associated with AChR protein complexes
to be translated. Bringing together synaptic transcripts may also
increase the local concentrations of the translational products
and facilitate the assembly of multimeric structures forming the
postsynaptic NMJ.
In the CNS, Stau1 is located in the somatodendritic regions of
neuronal cells [27,28], and mediates the delivery of RNA granules
[29]. Stau1 transports mRNA encoding Shank1, a postsynaptic scaf-
folding protein, to the postsynaptic density of excitatory synapses
in the brain through the interaction with the motor protein KIF5
[30]. Down-regulation of Stau1 in hippocampal slices results in im-
paired late form LTP and elongated dendritic spines, revealing the
critical roles of Stau1 in regulating synaptic strength and the for-
mation and maturation of synaptic morphology [31,32]. In accor-
dance with its role as a synaptic regulator in central synapses,
3116 Y.-F. Chang et al. / FEBS Letters 586 (2012) 3111–3116Stau1 is found co-localized with AChR in postsynaptic NMJ and its
protein levels are up-regulated in C2C12 myotubes by agrin [19].
The present study further supports that Stau1 is involved in the
formation and maturation of NMJ by showing that Stau1 associates
with Chrna1 mRNA in an agrin-dependent manner, and that down
regulation of Stau1 results in defective AChR clustering. However,
how such defects in AChR clustering are caused by the lack of
Stau1-mediated Chrna1 mRNA localization requires further study.
In conclusion, our observations indicate that agrin-inducible,
staufen-mediated post-transcriptional events operate in the post-
synaptic NMJ, and highlight the need for future studies to deter-
mine the extent and the detailed mechanism by which such
post-transcriptional events participate in the formation of the
postsynaptic NMJ.
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